NEWS

Feb 26, 2019
A research team, led by Dennis Drayna, Ph.D., chief of the Section on Genetics of Communication Disorders at the National Institute on Deafness and Other Communication Disorders (NIDCD), conducted detailed genetic analyses on 1,300 adults. A genetic...
Jan 29, 2019
The National Cancer Institute (NCI), through the NCI Technology Transfer Center (TTC), now offers a term-limited, exclusive Start-Up Evaluation Option License to start-up companies developing early-stage vaccine, therapeutic, device, and certain...
Jan 3, 2019
Proposal(s) are sought in response to RFP # NIH-OD-OLAO-OA-(PLS)-2019 for Patent-Legal Services. This solicitation is full and open to ALL capable business concerns in the U.S. The North American Industry Classification System (NAICS) code for this...

New & Updated Opportunities

Feb 26, 2019

Zika virus infection during pregnancy can cause microcephaly and other severe birth defects. The CDC Zika MAC-ELISA (IgM antibody capture enzyme-linked immunosorbent...

Feb 26, 2019

Streptococcus pneumoniae (S. pneumoniae) bacteria, or pneumococcus, can cause many types of illnesses. These range from ear and sinus infections to life-...

Feb 12, 2019

Papillomavirus pseudoviruses that comprise the L1/L2 capsid proteins can package a wide variety of non-viral DNA plasmids and deliver the packaged genetic material to...

SPOTLIGHT

The Cure Sickle Cell Initiative was launched by the National Heart, Lung, and Blood Institute (NHLBI) to build a nationwide commitment in finding new treatments and personalized care for this hereditary red blood cell disorder. Sickle cell disease affects about 100,000 Americans, many of whom are African American, and over 20 million people worldwide. Since founded in 1948, NHLBI has the long tradition of advancing research on understanding of the sickle cell disease and improving its clinical care. NHLBI also offers many sickle cell disease resources, including publications and videos to help patients and health professionals to learn about treatment and pain management strategies.

Cure Sickle Cell Initiative will actively engage and positively motivate the sickle cell disease community of patients, family members, caregivers, academic institutions, advocacy groups, pharmaceutical companies, federal agencies and biotechnology companies to work together on a path to...

Read More...